#Eclipsebio
LightNews LightNews
bioinfoblogs.bsky.social
📝 Eclipsebio expands its RNA characterization capabilities with multi-attribute nanopore-based sequencing assay eST...
✍️ RNA-Seq Blog
Eclipsebio expands its RNA characterization capabilities with multi-attribute nanopore-based sequencing assay eSTRAND RNA QC™
Article de RNA-Seq Blog
www.rna-seqblog.com
September 25, 2026 at 6:53 AM
activemotifusa.bsky.social
Don't miss this LIVE Event 🙌 Feb 20th, 9:00 AM PST

⭐ Comprehensive Characterization of mRNA-based Gene Editing, Wayne Doyle, PhD - Eclipsebio

⭐ Using DISCOVER-Seq to Reveal Off-target Effects of #CRISPR-Cas9, Katelyn Mortenson, PhD, Active Motif

Zoom Registration➡️ bit.ly/412G59o
February 5, 2025 at 3:43 PM
bioinfoblogs.bsky.social
📝 Eclipsebio expands its RNA characterization capabilities with multi-attribute nanopore-based sequencing assay eSTRAND RNA QC™
✍️ RNA-Seq Blog
Eclipsebio expands its RNA characterization capabilities with multi-attribute nanopore-based sequencing assay eSTRAND RNA QC™
Article de RNA-Seq Blog
www.rna-seqblog.com
September 11, 2026 at 6:51 AM
newsen.bsky.social
Eclipsebio Launches eSTRAND RNA QC™ to Enhance RNA Characterization for Therapeutics#United_States#San_Diego#Eclipsebio#RNA_QC#eSTRAND_RNA_QC
Eclipsebio Launches eSTRAND RNA QC™ to Enhance RNA Characterization for Therapeutics
Eclipse Bioinnovations presents eSTRAND RNA QC™, a groundbreaking assay that utilizes nanopore sequencing to improve RNA characterization for therapeutic development.
third-news.com
September 1, 2026 at 1:05 PM
stephenturner.us
eCV: Enhanced coefficient of variation and IDR extensions for reproducibility assessment of high-throughput experiments with multiple replicates www.biorxiv.org/content/10.1... R pkg: github.com/eclipsebio/eCV
GitHub - eclipsebio/eCV
Contribute to eclipsebio/eCV development by creating an account on GitHub.
github.com
January 4, 2024 at 8:00 PM
medcloudinsider.bsky.social
Eclipsebio has launched eCOMPASS, an AI-enabled platform for RNA therapeutic development that links computational analysis with lab workflows to support faster design, testing and validation.

Explore what this means for RNA drug development: https://ow.ly/XHjB50YNVuK

#AI #Biotech #RNA
Eclipsebio Launches AI Platform to Support RNA Therapeutic Development -- MedCloudInsider
New lab-in-the-loop system aims to integrate AI with experimental workflows for faster drug discovery.
ow.ly
April 22, 2026 at 2:03 PM
newsen.bsky.social
Eclipsebio Enhances eCOMPASS™ with eSENSE Break™ for RNA Analysis#USA#San_Diego#Eclipsebio#eCOMPASS#RNA_Fragmentation
Eclipsebio Enhances eCOMPASS™ with eSENSE Break™ for RNA Analysis
Eclipsebio unveils eSENSE Break™, part of the eCOMPASS™ platform, for precise mapping of RNA fragmentation at nucleotide-level resolution. This innovation enhances RNA therapeutic development.
third-news.com
June 1, 2026 at 4:14 PM
newsen.bsky.social
Eclipsebio Introduces eCOMPASS™: Revolutionizing RNA Therapy Development with AI#USA#San_Diego#RNA_Therapeutics#Eclipsebio#eCOMPASS™
Eclipsebio Introduces eCOMPASS™: Revolutionizing RNA Therapy Development with AI
Eclipsebio's groundbreaking eCOMPASS™ integrates AI-driven RNA design and deep characterization, enabling expedited therapeutic development and enhanced efficiency.
third-news.com
April 20, 2026 at 1:33 PM
activemotifusa.bsky.social
Don't miss this LIVE event happening April 17th
📅 bit.ly/3RaXQNX

*Detecting Cell Subpopulations in Cancer Samples Using Multiome Analysis || Michael Garbati, Ph.D., Active Motif

*Powering Cancer Drug Discovery with RNA & NGS: From Targets to Validation || Wayne Doyle, Ph.D., EclipseBio
Welcome! You are invited to join a webinar: Cutting Edge Approaches for Cancer Target Discovery and Validation. After registering, you will receive a confirmation email about joining the webinar.
In this webinar, Active Motif and Eclipsebio partner to discuss cutting edge techniques for cancer target discovery and validation, including RNA-Seq and Multiome Analysis. The live online event will ...
bit.ly
March 19, 2025 at 10:38 PM
l2plabs.bsky.social
Eclipsebio Launches eCOMPASS™, an AI-Enabled Lab-in-the-Loop Platform for RNA Therapeutic Development
Eclipsebio's eCOMPASS™ platform integrates AI-optimized RNA design (eNAVIGATE™), in-house prototyping at R&D scale, and deep sequencing-based characterization (eMERGE™) into a single iterative workflow. In a Cas9 mRNA case study, eCOMPASS-designed candidates achieved a 400% increase in...
dlvr.it
April 20, 2026 at 1:07 PM